Authors:
Sun, WJ
Stevenson, JP
Gallagher, M
Giantonio, B
Algazy, K
Haller, D
Vaughn, D
Raskay, BJ
O'Dwyer, PJ
Citation: Wj. Sun et al., A phase I trial of topotecan and gemcitabine administered weekly for 3 consecutive weeks to patients with advanced tumors, CANCER, 92(2), 2001, pp. 414-419
Authors:
Pertussini, E
Ratajczak, J
Majka, M
Vaughn, D
Ratajczak, MZ
Gewirtz, AM
Citation: E. Pertussini et al., Investigating the platelet-sparing mechanism of paclitaxel/carboplatin combination chemotherapy, BLOOD, 97(3), 2001, pp. 638-644
Authors:
Nye, JS
Hayes, EA
Amendola, M
Vaughn, D
Charrow, J
McLone, DG
Speer, MC
Nance, WE
Pandya, A
Citation: Js. Nye et al., Myelocystocele-cloacal exstrophy in a pedigree with a mitochondrial 12S rRNA mutation, aminoglycoside-induced deafness, pigmentary disturbances, and spinal anomalies, TERATOLOGY, 61(3), 2000, pp. 165-171
Authors:
Shapiro, JD
Harold, N
Takimoto, C
Hamilton, JM
Vaughn, D
Chen, A
Steinberg, SM
Liewehr, D
Allegra, C
Monahan, B
Lash, A
Grollman, F
Flemming, D
Behan, K
Johnston, PG
Haller, D
Quinn, M
Morrison, G
Grem, JL
Citation: Jd. Shapiro et al., A pilot study of interferon alpha-2a, fluorouracil, and leucovorin given with granulocyte-macrophage colony stimulating factor in advanced gastrointestinal adenocarcinoma, CLIN CANC R, 5(9), 1999, pp. 2399-2408